Acidic Extracellular PH Promotes Experimental Metastasis of Human Melanoma Cells in Athymic Nude Mice
Overview
Affiliations
Extracellular pH (pH(e)) is lower in many tumors than in the corresponding normal tissue. The significance of acidic pH(e) in the development of metastatic disease was investigated in the present work. Human melanoma cells (A-07, D-12, and T-22) were cultured in vitro at pH(e) 6.8 or 7.4 (control) before being inoculated into the tail vein of BALB/c nu/nu mice for formation of experimental pulmonary metastases. Cell invasiveness was studied in vitro by using Matrigel invasion chambers and angiogenesis was studied in vivo by using an intradermal assay. Protein secretion was measured by ELISA and immunocapture assays. Cells cultured at acidic pH(e) showed increased secretion of proteinases and proangiogenic factors, enhanced invasive and angiogenic potential, and enhanced potential to develop experimental metastases. Acidity-induced metastasis was inhibited by treatment with the general matrix metalloproteinase (MMP) inhibitor GM6001, the general cysteine proteinase inhibitor E-64, or blocking antibody against vascular endothelial growth factor-A (VEGF-A) or interleukin-8 (IL-8). Our study indicates that acidic pH(e) promotes experimental pulmonary metastasis in A-07, D-12, and T-22 human melanoma cells by a common mechanism involving acidity-induced up-regulation of the proteolytic enzymes MMP-2, MMP-9, cathepsin B, and cathepsin L and acidity-induced up-regulation of the proangiogenic factors VEGF-A and IL-8. One consequence of this observation is that treatment strategies involving deliberate tumor acidification to improve the efficacy of chemotherapy, photodynamic therapy, and hyperthermia should be avoided. Moreover, the possibility that the pH(e) of the primary tumor may be an important prognostic parameter for melanoma patients merits clinical investigation.
Blastocyst-Derived Lactate as a Key Facilitator of Implantation.
Gurner K, Gardner D Biomolecules. 2025; 15(1).
PMID: 39858494 PMC: 11764449. DOI: 10.3390/biom15010100.
Xiao L, Li X, Yu H, Qiu R, Zhai Z, Ding W World J Gastroenterol. 2024; 30(47):5032-5054.
PMID: 39713169 PMC: 11612860. DOI: 10.3748/wjg.v30.i47.5032.
Thews O, Reime S, Dubourg V, Riemann A Adv Exp Med Biol. 2024; 1463:285-291.
PMID: 39400837 DOI: 10.1007/978-3-031-67458-7_47.
Bone targeted nano-drug and nano-delivery.
Wu Y, Sun B, Tang Y, Shen A, Lin Y, Zhao X Bone Res. 2024; 12(1):51.
PMID: 39231955 PMC: 11375042. DOI: 10.1038/s41413-024-00356-2.
Mechanical Constraints in Tumor Guide Emergent Spatial Patterns of Glioblastoma Cancer Stem Cells.
Luu N, Zhang S, Lam R, Chen W Mechanobiol Med. 2024; 2(1).
PMID: 38770108 PMC: 11105673. DOI: 10.1016/j.mbm.2023.100027.